CM
CAI

CastleKnight Management’s Caris Life Sciences CAI Stock Holding History

CastleKnight Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36M Buy
132,236
+91,200
+222% +$1.63M 0.03% 288
2026
Q1 		$734K Buy
41,036
+30,600
+293% +$669K 0.01% 380
2025
Q4 		$282K Hold
10,436
– – 0.01% 336
2025
Q3 		$316K Sell
10,436
-102,994
-91% -$3.28M 0.01% 417
2025
Q2 		$3.03M Buy
+113,430
New +$3.06M 0.09% 169

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

CastleKnight Management's CAI Position: Q2 2026 in Review

CastleKnight Management increased its Caris Life Sciences (CAI) stake by 222% in Q2 2026, buying an estimated $1.63M and bringing the position to 132,236 shares worth $2.36M. The position accounts for 0.03% of the portfolio, ranked #288.

CastleKnight Management first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.03M in Q2 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • CastleKnight Management held 132,236 shares of Caris Life Sciences worth $2.36M as of Q2 2026.
  • CastleKnight Management bought 91,200 Caris Life Sciences shares in Q2 2026, an estimated $1.63M.
  • Caris Life Sciences made up 0.03% of CastleKnight Management's portfolio in Q2 2026, its #288 holding.
  • CastleKnight Management first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • CastleKnight Management's Caris Life Sciences position peaked at $3.03M in Q2 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on CastleKnight Management's 13F filing for Q2 2026, filed 14 Aug 2026.